Go to deals
Healthcare

IMD International Medical Devices has raised funds

IMD International Medical Devices has completed an IPO on the Euronext Growth Milan market, raising a total of US$6.5 million. The funds will be used to strengthen its competitive positioning in the market and implement a growth strategy, both in Italy and abroad.

IMD International Medical Devices designs, develops, manufactures and markets diverse X-ray diagnostic systems as well as components for radiology and medical clinics.

Oaklins Italy’s parent company Banca Akros acted as the Euronext Growth advisor, global coordinator and joint bookrunner in this transaction.

Talk to the deal team

Giulio Greco

Managing Director
Milan, Italy
Oaklins Italy

Giuliano Altieri

Director
Milan, Italy
Oaklins Italy

Nicola Biancoli

Associate
Milan, Italy
Oaklins Italy

Marco Valsecchi

Associate
Milan, Italy
Oaklins Italy

Related deals

Ebidco has finalized a voluntary public tender offer for the shares of Eles Semiconductor Equipment
Private Equity | Industrial Machinery & Components

Ebidco has finalized a voluntary public tender offer for the shares of Eles Semiconductor Equipment

Ebidco S.r.l. has completed a voluntary public tender offer for the shares of Eles Semiconductor Equipment S.p.A.

Learn more
Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Healthcare

Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval

Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.

Learn more
Aedes has finalized a rights issue
Real Estate

Aedes has finalized a rights issue

Aedes S.p.A. has successfully finalized a rights issue to support the objectives of the group’s 2024-2028 business plan and the relaunch of its business.

Learn more